This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2020 May 12;323(18):1769-1770.

doi: 10.1001/jama.2020.4812.

COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?

Ankit B Patel¹, Ashish Verma¹

Affiliations

PMID: 32208485
DOI: 10.1001/jama.2020.4812

COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?

Ankit B Patel et al. JAMA. 2020.

. 2020 May 12;323(18):1769-1770.

doi: 10.1001/jama.2020.4812.

Authors

Ankit B Patel¹, Ashish Verma¹

Affiliation

¹ Renal Division, Brigham and Women's Hospital, Boston, Massachusetts.

PMID: 32208485
DOI: 10.1001/jama.2020.4812

No abstract available

PubMed Disclaimer

Similar articles

A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
Wang Z, Zhang D, Wang S, Jin Y, Huan J, Wu Y, Xia C, Li Z, Qi X, Zhang D, Han X, Zhu X, Qu Y, Wang Q. Wang Z, et al. Med Sci Monit. 2020 Sep 24;26:e926651. doi: 10.12659/MSM.926651. Med Sci Monit. 2020. PMID: 32969367 Free PMC article.
A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).
Talreja H, Tan J, Dawes M, Supershad S, Rabindranath K, Fisher J, Valappil S, van der Merwe V, Wong L, van der Merwe W, Paton J. Talreja H, et al. N Z Med J. 2020 Apr 3;133(1512):85-87. N Z Med J. 2020. PMID: 32242182
Facts and reflections on COVID-19 and anti-hypertensives drugs.
Marin GH. Marin GH. Drug Discov Ther. 2020 May 6;14(2):105-106. doi: 10.5582/ddt.2020.01017. Epub 2020 Mar 26. Drug Discov Ther. 2020. PMID: 32213760
[The RAAS and SARS-CoV-2: A riddle to solve].
Choi M, Aiello EA, Ennis IL, Villa-Abrille MC. Choi M, et al. Hipertens Riesgo Vasc. 2020 Oct-Dec;37(4):169-175. doi: 10.1016/j.hipert.2020.05.005. Epub 2020 May 27. Hipertens Riesgo Vasc. 2020. PMID: 32527699 Free PMC article. Review. Spanish.
The renin-angiotensin system - a therapeutic target in COVID-19?
Sturrock BR, Milne KM, Chevassut TJ. Sturrock BR, et al. Clin Med (Lond). 2020 Jul;20(4):e72-e75. doi: 10.7861/clinmed.2020-0146. Epub 2020 May 15. Clin Med (Lond). 2020. PMID: 32414711 Free PMC article. Review.

See all similar articles

Cited by

Impact of High Troponin Level on the Outcome in COVID-19 Positive Patients.
Abohamr SI, Kattea MO, Abazid RM, Aldossari MA, Al Asiri N, Alhussini AU, Al Hussaini KI, Alasiri GA, Ali A, Elsheikh E. Abohamr SI, et al. J Multidiscip Healthc. 2024 Nov 1;17:4989-5000. doi: 10.2147/JMDH.S489622. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 39503002 Free PMC article.
The Long-Term Cardiovascular Impact of COVID-19: Pathophysiology, Clinical Manifestations, and Management.
Mukkawar RV, Reddy H, Rathod N, Kumar S, Acharya S. Mukkawar RV, et al. Cureus. 2024 Aug 10;16(8):e66554. doi: 10.7759/cureus.66554. eCollection 2024 Aug. Cureus. 2024. PMID: 39258051 Free PMC article. Review.
Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19.
Silva-Santos Y, Pagni RL, Gamon THM, de Azevedo MSP, Bielavsky M, Darido MLG, de Oliveira DBL, de Souza EE, Wrenger C, Durigon EL, Luvizotto MCR, Ackerman HC, Marinho CRF, Epiphanio S, Carvalho LJM. Silva-Santos Y, et al. Front Pharmacol. 2024 Jul 12;15:1414406. doi: 10.3389/fphar.2024.1414406. eCollection 2024. Front Pharmacol. 2024. PMID: 39070798 Free PMC article.
Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient.
García-Álvarez RM, Zapata-Cachafeiro M, Visos-Varela I, Rodríguez-Fernández A, Pintos-Rodríguez S, Piñeiro-Lamas M, Herdeiro TM, Figueiras A, Salgado-Barreira A; COVID-Drug Group. García-Álvarez RM, et al. Inflammopharmacology. 2024 Jun;32(3):1805-1815. doi: 10.1007/s10787-024-01475-2. Epub 2024 Apr 15. Inflammopharmacology. 2024. PMID: 38619761 Free PMC article.
Mapping ACE2 and TMPRSS2 co-expression in human brain tissue: implications for SARS-CoV-2 neurological manifestations.
Gupta T, Kumar M, Kaur UJ, Rao A, Bharti R. Gupta T, et al. J Neurovirol. 2024 Jun;30(3):316-326. doi: 10.1007/s13365-024-01206-x. Epub 2024 Apr 10. J Neurovirol. 2024. PMID: 38600308

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information